PDXK Knockout HeLa Cell Line
Cat.No.:
EDC90238
Species:
Human
Cell Name:
HeLa
Gene:
PDXK
Gene ID:
8566
Size:
1×10⁶ cells
PDXK Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90238 |
|---|---|
| Product Name | PDXK Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | PDXK |
| NCBI Gene ID | |
| Gene Synonyms | C21orf124|C21orf97|HEL-S-1a|HMSN6C|PKH|PNK|PRED79 |
| Summary |
The protein encoded by this gene phosphorylates vitamin B6, a step required for the conversion of vitamin B6 to pyridoxal-5-phosphate, an important cofactor in intermediary metabolism. The encoded protein is cytoplasmic and probably acts as a homodimer. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70% Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PDXK function, PDXK Knockout HeLa Cell Line or PDXK overexpression HeLa Cell Line?
The choice depends on whether you are studying PDXK (pyridoxal kinase)'s role in vitamin B6 metabolism or its emerging functions in cancer biology and chemotherapy response. The Knockout line is the standard tool for asking whether PDXK is required for converting pyridoxal, pyridoxine, and pyridoxamine to their 5'-phosphate forms — PDXK generates pyridoxal 5'-phosphate (PLP), the active vitamin B6 coenzyme essential for >150 enzymatic reactions. Overexpression is useful for studying PDXK's role in nucleoside analog drug activation.
For vitamin B6 biology and cancer research, the EDITGENE PDXK Knockout in HeLa enables study of PLP-dependent metabolism. PDXK has been characterized as activating nucleoside analog drugs (3'-azido-3'-deoxythymidine/AZT and others). Rescue with wild-type or kinase-dead PDXK is the standard specificity control. The knockout is valuable for studying PLP-dependent enzyme dependencies and B6-related neurological pathology.
What are the application scenarios for this model?
Primary applications:
• Pyridoxal 5'-phosphate (PLP) generation: cellular PLP quantification by LC-MS or PLP-dependent enzyme activity assays to characterize PDXK activity.
• B6-dependent enzyme functions: cystathionine β-synthase (CBS), GAD, AADC, and other PLP-dependent enzyme activity analysis.
• Nucleoside analog activation: AZT and related nucleoside analog activation studies given PDXK's role in nucleoside metabolism.
• B6 supplementation studies: cellular rescue of PDXK-null phenotypes by exogenous PLP versus pyridoxal supplementation.
EDITGENE recommends this model for researchers investigating vitamin B6 metabolism, PLP-dependent enzymes, and nucleoside analog drug activation.
Is this PDXK Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. PDXK rescue experiments require attention to kinase architecture:
• Construct design: use a codon-modified PDXK sequence with a small C-terminal tag (FLAG, HA). PDXK is a homodimeric kinase — preserve dimerization interface.
• Kinase-dead rescue: active site mutations affecting ATP binding abolish catalytic activity and serve as the standard specificity control.
• Functional readout: rescue should restore cellular PLP generation measured by LC-MS and downstream PLP-dependent enzyme activity.
HeLa transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download